1
|
Sisodiya SM, Gulcebi MI, Fortunato F, Mills JD, Haynes E, Bramon E, Chadwick P, Ciccarelli O, David AS, De Meyer K, Fox NC, Davan Wetton J, Koltzenburg M, Kullmann DM, Kurian MA, Manji H, Maslin MA, Matharu M, Montgomery H, Romanello M, Werring DJ, Zhang L, Friston KJ, Hanna MG. Climate change and disorders of the nervous system. Lancet Neurol 2024; 23:636-648. [PMID: 38760101 DOI: 10.1016/s1474-4422(24)00087-5] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/17/2023] [Revised: 02/12/2024] [Accepted: 02/27/2024] [Indexed: 05/19/2024]
Abstract
Anthropogenic climate change is affecting people's health, including those with neurological and psychiatric diseases. Currently, making inferences about the effect of climate change on neurological and psychiatric diseases is challenging because of an overall sparsity of data, differing study methods, paucity of detail regarding disease subtypes, little consideration of the effect of individual and population genetics, and widely differing geographical locations with the potential for regional influences. However, evidence suggests that the incidence, prevalence, and severity of many nervous system conditions (eg, stroke, neurological infections, and some mental health disorders) can be affected by climate change. The data show broad and complex adverse effects, especially of temperature extremes to which people are unaccustomed and wide diurnal temperature fluctuations. Protective measures might be possible through local forecasting. Few studies project the future effects of climate change on brain health, hindering policy developments. Robust studies on the threats from changing climate for people who have, or are at risk of developing, disorders of the nervous system are urgently needed.
Collapse
Affiliation(s)
- Sanjay M Sisodiya
- Department of Clinical and Experimental Epilepsy, UCL Queen Square Institute of Neurology, University College London, London, UK; Chalfont Centre for Epilepsy, Chalfont-St-Peter, UK.
| | - Medine I Gulcebi
- Department of Clinical and Experimental Epilepsy, UCL Queen Square Institute of Neurology, University College London, London, UK; Chalfont Centre for Epilepsy, Chalfont-St-Peter, UK
| | - Francesco Fortunato
- Department of Clinical and Experimental Epilepsy, UCL Queen Square Institute of Neurology, University College London, London, UK; Chalfont Centre for Epilepsy, Chalfont-St-Peter, UK
| | - James D Mills
- Department of Clinical and Experimental Epilepsy, UCL Queen Square Institute of Neurology, University College London, London, UK; Chalfont Centre for Epilepsy, Chalfont-St-Peter, UK
| | - Ethan Haynes
- Department of Clinical and Experimental Epilepsy, UCL Queen Square Institute of Neurology, University College London, London, UK; Chalfont Centre for Epilepsy, Chalfont-St-Peter, UK
| | - Elvira Bramon
- Division of Psychiatry, University College London, London, UK
| | - Paul Chadwick
- Centre for Behaviour Change, University College London, London, UK
| | - Olga Ciccarelli
- Department of Neuroinflammation, UCL Queen Square Institute of Neurology, University College London, London, UK; National Institute of Health Research University College London Hospitals Biomedical Research Centre, London, UK
| | - Anthony S David
- Division of Psychiatry, University College London, London, UK
| | - Kris De Meyer
- UCL Climate Action Unit, University College London, London, UK
| | - Nick C Fox
- Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, University College London, London, UK; Department of the UK Dementia Research Institute, UCL Queen Square Institute of Neurology, University College London, London, UK
| | | | - Martin Koltzenburg
- Department of Clinical and Movement Neuroscience, UCL Queen Square Institute of Neurology, University College London, London, UK
| | - Dimitri M Kullmann
- Department of Clinical and Experimental Epilepsy, UCL Queen Square Institute of Neurology, University College London, London, UK
| | - Manju A Kurian
- Department of Developmental Neurosciences, Zayed Centre for Research into Rare Disease in Children, UCL Great Ormond Street Institute of Child Health, London, UK
| | - Hadi Manji
- National Hospital for Neurology and Neurosurgery, London, UK
| | - Mark A Maslin
- Department of Geography, University College London, London, UK; Natural History Museum of Denmark, University of Copenhagen, Copenhagen, Denmark
| | - Manjit Matharu
- Headache and Facial Pain Group, UCL Queen Square Institute of Neurology, UCL and the National Hospital for Neurology and Neurosurgery, London, UK
| | - Hugh Montgomery
- Department of Medicine, University College London, London, UK
| | - Marina Romanello
- Institute for Global Health, University College London, London, UK
| | - David J Werring
- Stroke Research Centre, Department of Brain Repair and Rehabilitation, UCL Queen Square Institute of Neurology, University College London, London, UK
| | - Lisa Zhang
- Centre for Behaviour Change, University College London, London, UK
| | - Karl J Friston
- Wellcome Centre for Human Neuroimaging, UCL Queen Square Institute of Neurology, University College London, London, UK
| | - Michael G Hanna
- Centre for Neuromuscular Diseases, Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, University College London, London, UK; MRC International Centre for Genomic Medicine in Neuromuscular Diseases, Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, University College London, London, UK
| |
Collapse
|
2
|
Zeidman P, Friston K, Parr T. A primer on Variational Laplace (VL). Neuroimage 2023; 279:120310. [PMID: 37544417 PMCID: PMC10951963 DOI: 10.1016/j.neuroimage.2023.120310] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/30/2022] [Revised: 07/13/2023] [Accepted: 08/04/2023] [Indexed: 08/08/2023] Open
Abstract
This article details a scheme for approximate Bayesian inference, which has underpinned thousands of neuroimaging studies since its introduction 15 years ago. Variational Laplace (VL) provides a generic approach to fitting linear or non-linear models, which may be static or dynamic, returning a posterior probability density over the model parameters and an approximation of log model evidence, which enables Bayesian model comparison. VL applies variational Bayesian inference in conjunction with quadratic or Laplace approximations of the evidence lower bound (free energy). Importantly, update equations do not need to be derived for each model under consideration, providing a general method for fitting a broad class of models. This primer is intended for experimenters and modellers who may wish to fit models to data using variational Bayesian methods, without assuming previous experience of variational Bayes or machine learning. Accompanying code demonstrates how to fit different kinds of model using the reference implementation of the VL scheme in the open-source Statistical Parametric Mapping (SPM) software package. In addition, we provide a standalone software function that does not require SPM, in order to ease translation to other fields, together with detailed pseudocode. Finally, the supplementary materials provide worked derivations of the key equations.
Collapse
Affiliation(s)
- Peter Zeidman
- Wellcome Centre for Human Neuroimaging, UCL, 12 Queen Square, London WC1N 3AR, United Kingdom.
| | - Karl Friston
- Wellcome Centre for Human Neuroimaging, UCL, 12 Queen Square, London WC1N 3AR, United Kingdom
| | - Thomas Parr
- Wellcome Centre for Human Neuroimaging, UCL, 12 Queen Square, London WC1N 3AR, United Kingdom
| |
Collapse
|
3
|
Jin J, Zeidman P, Friston KJ, Kotov R. Inferring Trajectories of Psychotic Disorders Using Dynamic Causal Modeling. COMPUTATIONAL PSYCHIATRY (CAMBRIDGE, MASS.) 2023; 7:60-75. [PMID: 38774642 PMCID: PMC11104383 DOI: 10.5334/cpsy.94] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 07/15/2022] [Accepted: 06/27/2023] [Indexed: 05/24/2024]
Abstract
Introduction Illness course plays a crucial role in delineating psychiatric disorders. However, existing nosologies consider only its most basic features (e.g., symptom sequence, duration). We developed a Dynamic Causal Model (DCM) that characterizes course patterns more fully using dense timeseries data. This foundational study introduces the new modeling approach and evaluates its validity using empirical and simulated data. Methods A three-level DCM was constructed to model how latent dynamics produce symptoms of depression, mania, and psychosis. This model was fit to symptom scores of nine patients collected prospectively over four years, following first hospitalization. Simulated subjects based on these empirical data were used to evaluate model parameters at the subject-level. At the group-level, we tested the accuracy with which the DCM can estimate the latent course patterns using Parametric Empirical Bayes (PEB) and leave-one-out cross-validation. Results Analyses of empirical data showed that DCM accurately captured symptom trajectories for all nine subjects. Simulation results showed that parameters could be estimated accurately (correlations between generative and estimated parameters >= 0.76). Moreover, the model could distinguish different latent course patterns, with PEB correctly assigning simulated patients for eight of nine course patterns. When testing any pair of two specific course patterns using leave-one-out cross-validation, 30 out of 36 pairs showed a moderate or high out-of-samples correlation between the true group-membership and the estimated group-membership values. Conclusion DCM has been widely used in neuroscience to infer latent neuronal processes from neuroimaging data. Our findings highlight the potential of adopting this methodology for modeling symptom trajectories to explicate nosologic entities, temporal patterns that define them, and facilitate personalized treatment.
Collapse
Affiliation(s)
- Jingwen Jin
- Department of Psychology, The University of Hong Kong, Hong Kong SAR, China
- State Key Laboratory of Brain and Cognitive Sciences, The University of Hong Kong, Hong Kong SAR, China
| | - Peter Zeidman
- Wellcome Centre for Human Neuroimaging, University College London, UK
| | - Karl J. Friston
- Wellcome Centre for Human Neuroimaging, University College London, UK
| | - Roman Kotov
- Department of Psychiatry, Renaissance School of Medicine, Stony Brook University, USA
| |
Collapse
|
4
|
Safaie N, Kaveie M, Mardanian S, Mohammadi M, Abdol Mohamadi R, Nasri SA. Investigation of Factors Affecting COVID-19 and Sixth Wave Management Using a System Dynamics Approach. JOURNAL OF HEALTHCARE ENGINEERING 2022; 2022:4079685. [PMID: 36471726 PMCID: PMC9719431 DOI: 10.1155/2022/4079685] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/16/2022] [Revised: 07/12/2022] [Accepted: 07/29/2022] [Indexed: 11/04/2023]
Abstract
The COVID-19 pandemic has plunged the world into a health and economic crisis never seen before since the Spanish flu pandemic in 1918. The closure of schools and universities, the banning of rallies, and other social distancing in countries have been done to disrupt the transmission of the virus. Governments have planned to reduce restrictions on corona management by implementing vaccination programs. This research aims to better understand the Coronavirus disease's behavior, identify the prevalent factors, and adopt effective policies to control the pandemic. This study examines the different scenarios of releasing the constraints and returning to normal conditions before Corona to analyze the results of different scenarios to prevent the occurrence of subsequent peaks. The system dynamics approach is an effective means of studying COVID-19's behavioral characteristics. The factors that affect Coronavirus disease outbreak and control by expanding the basic SEIR model, interventions, and policies, such as vaccination, were investigated in this research. Based on the obtained results, the most critical factor in reducing the prevalence of the disease is reducing the behavioral risks of people and increasing the vaccination process. Observance of hygienic principles leads to disruption of the transmission chain, and vaccination increases the immunity of individuals against the acute type of infection. In addition, the closure of businesses and educational centers, along with government support for incomes, effectively controls and reduces the pandemic, which requires cooperation between the people and the government. In a situation where a new type of corona has spread, if the implementation of the policy of reducing restrictions and reopening schools and universities is done without planning, it will cause a lot of people to suffer.
Collapse
Affiliation(s)
- Nasser Safaie
- Department of Industrial Engineering, K. N. Toosi University of Technology, Tehran, Iran
| | - Maryam Kaveie
- Department of Industrial Engineering, K. N. Toosi University of Technology, Tehran, Iran
| | - Siroos Mardanian
- Department of Industrial Engineering, K. N. Toosi University of Technology, Tehran, Iran
| | - Mina Mohammadi
- Department of Industrial Engineering, K. N. Toosi University of Technology, Tehran, Iran
| | - Rasoul Abdol Mohamadi
- Department of Industrial Engineering, K. N. Toosi University of Technology, Tehran, Iran
| | - Seyed Amir Nasri
- Department of Industrial Engineering, K. N. Toosi University of Technology, Tehran, Iran
| |
Collapse
|
5
|
Dynamic causal modelling of COVID-19 and its mitigations. Sci Rep 2022; 12:12419. [PMID: 35859054 PMCID: PMC9298167 DOI: 10.1038/s41598-022-16799-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/09/2021] [Accepted: 07/14/2022] [Indexed: 11/08/2022] Open
Abstract
This technical report describes the dynamic causal modelling of mitigated epidemiological outcomes during the COVID-9 coronavirus outbreak in 2020. Dynamic causal modelling is a form of complex system modelling, which uses ‘real world’ timeseries to estimate the parameters of an underlying state space model using variational Bayesian procedures. Its key contribution—in an epidemiological setting—is to embed conventional models within a larger model of sociobehavioural responses—in a way that allows for (relatively assumption-free) forecasting. One advantage of using variational Bayes is that one can progressively optimise the model via Bayesian model selection: generally, the most likely models become more expressive as more data becomes available. This report summarises the model (on 6-Nov-20), eight months after the inception of dynamic causal modelling for COVID-19. This model—and its subsequent updates—is used to provide nowcasts and forecasts of latent behavioural and epidemiological variables as an open science resource. The current report describes the underlying model structure and the rationale for the variational procedures that underwrite Bayesian model selection.
Collapse
|
6
|
Ramstead MJD, Seth AK, Hesp C, Sandved-Smith L, Mago J, Lifshitz M, Pagnoni G, Smith R, Dumas G, Lutz A, Friston K, Constant A. From Generative Models to Generative Passages: A Computational Approach to (Neuro) Phenomenology. REVIEW OF PHILOSOPHY AND PSYCHOLOGY 2022; 13:829-857. [PMID: 35317021 PMCID: PMC8932094 DOI: 10.1007/s13164-021-00604-y] [Citation(s) in RCA: 9] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Accepted: 10/28/2021] [Indexed: 12/16/2022]
Abstract
This paper presents a version of neurophenomenology based on generative modelling techniques developed in computational neuroscience and biology. Our approach can be described as computational phenomenology because it applies methods originally developed in computational modelling to provide a formal model of the descriptions of lived experience in the phenomenological tradition of philosophy (e.g., the work of Edmund Husserl, Maurice Merleau-Ponty, etc.). The first section presents a brief review of the overall project to naturalize phenomenology. The second section presents and evaluates philosophical objections to that project and situates our version of computational phenomenology with respect to these projects. The third section reviews the generative modelling framework. The final section presents our approach in detail. We conclude by discussing how our approach differs from previous attempts to use generative modelling to help understand consciousness. In summary, we describe a version of computational phenomenology which uses generative modelling to construct a computational model of the inferential or interpretive processes that best explain this or that kind of lived experience.
Collapse
Affiliation(s)
- Maxwell J. D. Ramstead
- Wellcome Centre for Human Neuroimaging, University College London, London, UK
- VERSES Research Lab and Spatial Web Foundation, Los Angeles, California USA
| | - Anil K. Seth
- School of Engineering and Informatics, University of Sussex, Brighton, BN1 9QJ UK
- Canadian Institute for Advanced Research (CIFAR), Program on Brain, Mind, and Consciousness, Toronto, Ontario, M5G 1M1 Canada
| | - Casper Hesp
- Wellcome Centre for Human Neuroimaging, University College London, London, UK
- Department of Psychology, University of Amsterdam, Science Park 904, 1098 XH Amsterdam, Netherlands
- Amsterdam Brain and Cognition Centre, University of Amsterdam, Science Park 904, 1098 XH Amsterdam, Netherlands
- Institute for Advanced Study, University of Amsterdam, Oude Turfmarkt 147, 1012 GC Amsterdam, Netherlands
| | - Lars Sandved-Smith
- Wellcome Centre for Human Neuroimaging, University College London, London, UK
- Lyon Neuroscience Research Centre, INSERM U1028, CNRS UMR5292, Lyon 1 University, Lyon, France
| | - Jonas Mago
- Wellcome Centre for Human Neuroimaging, University College London, London, UK
- Integrated Program in Neuroscience, Department of Neuroscience, McGill University, Montreal, Canada
- Division of Social and Transcultural Psychiatry, McGill University, Montreal, Canada
| | - Michael Lifshitz
- Division of Social and Transcultural Psychiatry, McGill University, Montreal, Canada
- Lady Davis Institute for Medical Research, Montreal Jewish General Hospital, Montreal, Canada
| | - Giuseppe Pagnoni
- Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy
- Center for Neuroscience and Neurotechnology, University of Modena and Reggio Emilia, Modena, Italy
| | - Ryan Smith
- Laureate Institute for Brain Research, Tulsa, Oklahoma USA
| | - Guillaume Dumas
- CHU Sainte-Justine Research Center, Department of Psychiatry, University of Montreal, Montreal, Canada
- Mila – Quebec Artificial Intelligence Institute, University of Montreal, Montreal, Canada
| | - Antoine Lutz
- Lyon Neuroscience Research Centre, INSERM U1028, CNRS UMR5292, Lyon 1 University, Lyon, France
| | - Karl Friston
- Wellcome Centre for Human Neuroimaging, University College London, London, UK
- VERSES Research Lab and Spatial Web Foundation, Los Angeles, California USA
| | - Axel Constant
- Charles Perkins Centre, The University of Sydney, Sydney, Australia
| |
Collapse
|
7
|
Sarkar A, Harty S, Moeller AH, Klein SL, Erdman SE, Friston KJ, Carmody RN. The gut microbiome as a biomarker of differential susceptibility to SARS-CoV-2. Trends Mol Med 2021; 27:1115-1134. [PMID: 34756546 PMCID: PMC8492747 DOI: 10.1016/j.molmed.2021.09.009] [Citation(s) in RCA: 25] [Impact Index Per Article: 8.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/30/2021] [Revised: 09/28/2021] [Accepted: 09/29/2021] [Indexed: 02/07/2023]
Abstract
Coronavirus disease 2019 (COVID-19) continues to exact a devastating global toll. Ascertaining the factors underlying differential susceptibility and prognosis following viral exposure is critical to improving public health responses. We propose that gut microbes may contribute to variation in COVID-19 outcomes. We synthesise evidence for gut microbial contributions to immunity and inflammation, and associations with demographic factors affecting disease severity. We suggest mechanisms potentially underlying microbially mediated differential susceptibility to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). These include gut microbiome-mediated priming of host inflammatory responses and regulation of endocrine signalling, with consequences for the cellular features exploited by SARS-CoV-2 virions. We argue that considering gut microbiome-mediated mechanisms may offer a lens for appreciating differential susceptibility to SARS-CoV-2, potentially contributing to clinical and epidemiological approaches to understanding and managing COVID-19.
Collapse
Affiliation(s)
- Amar Sarkar
- Department of Human Evolutionary Biology, Harvard University, Cambridge, MA, USA.
| | - Siobhán Harty
- Tandy Court, Spitalfields, Dublin 8, D08 RP20, Ireland
| | - Andrew H Moeller
- Department of Ecology and Evolutionary Biology, Cornell University, Ithaca, NY, USA
| | - Sabra L Klein
- W. Harry Feinstone Department of Molecular Microbiology and Immunology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
| | - Susan E Erdman
- Division of Comparative Medicine, Massachusetts Institute of Technology, Cambridge, MA, USA
| | - Karl J Friston
- Wellcome Centre for Human Neuroimaging, University College London, London, UK
| | - Rachel N Carmody
- Department of Human Evolutionary Biology, Harvard University, Cambridge, MA, USA.
| |
Collapse
|
8
|
Campillo-Funollet E, Van Yperen J, Allman P, Bell M, Beresford W, Clay J, Dorey M, Evans G, Gilchrist K, Memon A, Pannu G, Walkley R, Watson M, Madzvamuse A. Predicting and forecasting the impact of local outbreaks of COVID-19: use of SEIR-D quantitative epidemiological modelling for healthcare demand and capacity. Int J Epidemiol 2021; 50:1103-1113. [PMID: 34244764 PMCID: PMC8407866 DOI: 10.1093/ije/dyab106] [Citation(s) in RCA: 12] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 05/03/2021] [Indexed: 02/05/2023] Open
Abstract
BACKGROUND The world is experiencing local/regional hotspots and spikes in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes COVID-19 disease. We aimed to formulate an applicable epidemiological model to accurately predict and forecast the impact of local outbreaks of COVID-19 to guide the local healthcare demand and capacity, policy-making and public health decisions. METHODS The model utilized the aggregated daily COVID-19 situation reports (including counts of daily admissions, discharges and bed occupancy) from the local National Health Service (NHS) hospitals and COVID-19-related weekly deaths in hospitals and other settings in Sussex (population 1.7 million), Southeast England. These data sets corresponded to the first wave of COVID-19 infections from 24 March to 15 June 2020. A novel epidemiological predictive and forecasting model was then derived based on the local/regional surveillance data. Through a rigorous inverse parameter inference approach, the model parameters were estimated by fitting the model to the data in an optimal sense and then subsequent validation. RESULTS The inferred parameters were physically reasonable and matched up to the widely used parameter values derived from the national data sets by Biggerstaff M, Cowling BJ, Cucunubá ZM et al. (Early insights from statistical and mathematical modeling of key epidemiologic parameters of COVID-19, Emerging infectious diseases. 2020;26(11)). We validate the predictive power of our model by using a subset of the available data and comparing the model predictions for the next 10, 20 and 30 days. The model exhibits a high accuracy in the prediction, even when using only as few as 20 data points for the fitting. CONCLUSIONS We have demonstrated that by using local/regional data, our predictive and forecasting model can be utilized to guide the local healthcare demand and capacity, policy-making and public health decisions to mitigate the impact of COVID-19 on the local population. Understanding how future COVID-19 spikes/waves could possibly affect the regional populations empowers us to ensure the timely commissioning and organization of services. The flexibility of timings in the model, in combination with other early-warning systems, produces a time frame for these services to prepare and isolate capacity for likely and potential demand within regional hospitals. The model also allows local authorities to plan potential mortuary capacity and understand the burden on crematoria and burial services. The model algorithms have been integrated into a web-based multi-institutional toolkit, which can be used by NHS hospitals, local authorities and public health departments in other regions of the UK and elsewhere. The parameters, which are locally informed, form the basis of predicting and forecasting exercises accounting for different scenarios and impacts of COVID-19 transmission.
Collapse
Affiliation(s)
- Eduard Campillo-Funollet
- School of Life Sciences, Centre for Genome Damage and Stability, University of Sussex, Brighton, UK
| | - James Van Yperen
- Department of Mathematics, School of Mathematical and Physical Sciences, University of Sussex, Brighton, UK
| | | | - Michael Bell
- Public Health Intelligence and Adult Social Care, Brighton and Hove City Council, Hove, UK
| | - Warren Beresford
- Planning and Intelligence, Brighton and Hove, Sussex Commissioners, East Sussex, UK
| | - Jacqueline Clay
- Public Health and Social Research Unit, West Sussex County Council, Chichester, West Sussex, UK
| | - Matthew Dorey
- Public Health and Social Research Unit, West Sussex County Council, Chichester, West Sussex, UK
| | - Graham Evans
- Public Health Intelligence, East Sussex County Council, St Anne’s Crescent, Lewes, UK
| | - Kate Gilchrist
- Public Health Intelligence and Adult Social Care, Brighton and Hove City Council, Hove, UK
| | - Anjum Memon
- Department of Primary Care and Public Health, Brighton and Sussex Medical School, Brighton, UK
| | - Gurprit Pannu
- Sussex Health and Care Partnership, Millview Hospital, Hove, East Sussex, UK
| | - Ryan Walkley
- Public Health and Social Research Unit, West Sussex County Council, Chichester, West Sussex, UK
| | - Mark Watson
- Sussex Health and Care Partnership, Lewes, UK
| | - Anotida Madzvamuse
- Department of Mathematics, School of Mathematical and Physical Sciences, University of Sussex, Brighton, UK
| |
Collapse
|
9
|
Causal Information Rate. ENTROPY 2021; 23:e23081087. [PMID: 34441227 PMCID: PMC8394343 DOI: 10.3390/e23081087] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 07/24/2021] [Revised: 08/13/2021] [Accepted: 08/18/2021] [Indexed: 11/23/2022]
Abstract
Information processing is common in complex systems, and information geometric theory provides a useful tool to elucidate the characteristics of non-equilibrium processes, such as rare, extreme events, from the perspective of geometry. In particular, their time-evolutions can be viewed by the rate (information rate) at which new information is revealed (a new statistical state is accessed). In this paper, we extend this concept and develop a new information-geometric measure of causality by calculating the effect of one variable on the information rate of the other variable. We apply the proposed causal information rate to the Kramers equation and compare it with the entropy-based causality measure (information flow). Overall, the causal information rate is a sensitive method for identifying causal relations.
Collapse
|
10
|
Parr T, Bhat A, Zeidman P, Goel A, Billig AJ, Moran R, Friston KJ. Dynamic causal modelling of immune heterogeneity. Sci Rep 2021; 11:11400. [PMID: 34059775 PMCID: PMC8167139 DOI: 10.1038/s41598-021-91011-x] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/29/2020] [Accepted: 05/20/2021] [Indexed: 02/06/2023] Open
Abstract
An interesting inference drawn by some COVID-19 epidemiological models is that there exists a proportion of the population who are not susceptible to infection-even at the start of the current pandemic. This paper introduces a model of the immune response to a virus. This is based upon the same sort of mean-field dynamics as used in epidemiology. However, in place of the location, clinical status, and other attributes of people in an epidemiological model, we consider the state of a virus, B and T-lymphocytes, and the antibodies they generate. Our aim is to formalise some key hypotheses as to the mechanism of resistance. We present a series of simple simulations illustrating changes to the dynamics of the immune response under these hypotheses. These include attenuated viral cell entry, pre-existing cross-reactive humoral (antibody-mediated) immunity, and enhanced T-cell dependent immunity. Finally, we illustrate the potential application of this sort of model by illustrating variational inversion (using simulated data) of this model to illustrate its use in testing hypotheses. In principle, this furnishes a fast and efficient immunological assay-based on sequential serology-that provides a (1) quantitative measure of latent immunological responses and (2) a Bayes optimal classification of the different kinds of immunological response (c.f., glucose tolerance tests used to test for insulin resistance). This may be especially useful in assessing SARS-CoV-2 vaccines.
Collapse
Affiliation(s)
- Thomas Parr
- Wellcome Centre for Human Neuroimaging, Queen Square Institute of Neurology, London, UK.
| | - Anjali Bhat
- Wellcome Centre for Human Neuroimaging, Queen Square Institute of Neurology, London, UK
| | - Peter Zeidman
- Wellcome Centre for Human Neuroimaging, Queen Square Institute of Neurology, London, UK
| | - Aimee Goel
- Royal Stoke University Hospital, Stoke-on-Trent, UK
| | | | - Rosalyn Moran
- Centre for Neuroimaging Science, Department of Neuroimaging, IoPPN, King's College London, London, UK
| | - Karl J Friston
- Wellcome Centre for Human Neuroimaging, Queen Square Institute of Neurology, London, UK
| |
Collapse
|
11
|
Parr T. Message Passing and Metabolism. ENTROPY (BASEL, SWITZERLAND) 2021; 23:606. [PMID: 34068913 PMCID: PMC8156486 DOI: 10.3390/e23050606] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 03/30/2021] [Revised: 05/09/2021] [Accepted: 05/10/2021] [Indexed: 11/16/2022]
Abstract
Active inference is an increasingly prominent paradigm in theoretical biology. It frames the dynamics of living systems as if they were solving an inference problem. This rests upon their flow towards some (non-equilibrium) steady state-or equivalently, their maximisation of the Bayesian model evidence for an implicit probabilistic model. For many models, these self-evidencing dynamics manifest as messages passed among elements of a system. Such messages resemble synaptic communication at a neuronal network level but could also apply to other network structures. This paper attempts to apply the same formulation to biochemical networks. The chemical computation that occurs in regulation of metabolism relies upon sparse interactions between coupled reactions, where enzymes induce conditional dependencies between reactants. We will see that these reactions may be viewed as the movement of probability mass between alternative categorical states. When framed in this way, the master equations describing such systems can be reformulated in terms of their steady-state distribution. This distribution plays the role of a generative model, affording an inferential interpretation of the underlying biochemistry. Finally, we see that-in analogy with computational neurology and psychiatry-metabolic disorders may be characterized as false inference under aberrant prior beliefs.
Collapse
Affiliation(s)
- Thomas Parr
- Wellcome Centre for Human Neuroimaging, Queen Square Institute of Neurology, University College London, London WC1N 3AR, UK
| |
Collapse
|
12
|
Neagu M, Calina D, Docea AO, Constantin C, Filippini T, Vinceti M, Drakoulis N, Poulas K, Nikolouzakis TK, Spandidos DA, Tsatsakis A. Back to basics in COVID-19: Antigens and antibodies-Completing the puzzle. J Cell Mol Med 2021; 25:4523-4533. [PMID: 33734600 PMCID: PMC8107083 DOI: 10.1111/jcmm.16462] [Citation(s) in RCA: 32] [Impact Index Per Article: 10.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/31/2021] [Revised: 02/22/2021] [Accepted: 02/25/2021] [Indexed: 02/07/2023] Open
Abstract
The outbreak of the coronavirus disease 2019 (COVID-19) has gathered 1 year of scientific/clinical information. This informational asset should be thoroughly and wisely used in the coming year colliding in a global task force to control this infection. Epidemiology of this infection shows that the available estimates of SARS-CoV-2 infection prevalence largely depended on the availability of molecular testing and the extent of tested population. Within molecular diagnosis, the viability and infectiousness of the virus in the tested samples should be further investigated. Moreover, SARS-CoV-2 has a genetic normal evolution that is a dynamic process. The immune system participates to the counterattack of the viral infection by pathogen elimination, cellular homoeostasis, tissue repair and generation of memory cells that would be reactivated upon a second encounter with the same virus. In all these stages, we still have knowledge to be gathered regarding antibody persistence, protective effects and immunological memory. Moreover, information regarding the intense pro-inflammatory action in severe cases still lacks and this is important in stratifying patients for difficult to treat cases. Without being exhaustive, the review will cover these important issues to be acknowledged to further advance in the battle against the current pandemia.
Collapse
Affiliation(s)
- Monica Neagu
- Department of ImmunologyVictor Babes National Institute of PathologyBucharestRomania
- Department of PathologyColentina Clinical HospitalBucharestRomania
- Doctoral SchoolUniversity of BucharestBucharestRomania
| | - Daniela Calina
- Department of Clinical PharmacyUniversity of Medicine and Pharmacy of CraiovaCraiovaRomania
| | - Anca Oana Docea
- Department of ToxicologyUniversity of Medicine and Pharmacy of CraiovaCraiovaRomania
| | - Carolina Constantin
- Department of ImmunologyVictor Babes National Institute of PathologyBucharestRomania
- Department of PathologyColentina Clinical HospitalBucharestRomania
| | - Tommaso Filippini
- Section of Public HealthDepartment of Biomedical, Metabolic and Neural SciencesEnvironmental, Genetic and Nutritional Epidemiology Research Center (CREAGEN)University of Modena and Reggio EmiliaModenaItaly
| | - Marco Vinceti
- Section of Public HealthDepartment of Biomedical, Metabolic and Neural SciencesEnvironmental, Genetic and Nutritional Epidemiology Research Center (CREAGEN)University of Modena and Reggio EmiliaModenaItaly
- Department of EpidemiologyBoston University School of Public HealthBostonMAUSA
| | - Nikolaos Drakoulis
- Research Group of Clinical Pharmacology and PharmacogenomicsFaculty of PhrarmacySchool of Health SciencesNational and Kapodistrian University of AthensAthensGreece
| | - Konstantinos Poulas
- Department of PharmacyLaboratory of Molecular Biology and ImmunologyUniversity of PatrasPatrasGreece
| | | | | | - Aristidis Tsatsakis
- Department of Forensic Sciences and ToxicologyFaculty of MedicineUniversity of CreteHeraklionGreece
- Department of Analytical and Forensic Medical ToxicologySechenov UniversityMoscowRussia
| |
Collapse
|
13
|
COVID-19: Short term prediction model using daily incidence data. PLoS One 2021; 16:e0250110. [PMID: 33852642 PMCID: PMC8046206 DOI: 10.1371/journal.pone.0250110] [Citation(s) in RCA: 18] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/18/2020] [Accepted: 03/30/2021] [Indexed: 01/05/2023] Open
Abstract
Background Prediction of the dynamics of new SARS-CoV-2 infections during the current COVID-19 pandemic is critical for public health planning of efficient health care allocation and monitoring the effects of policy interventions. We describe a new approach that forecasts the number of incident cases in the near future given past occurrences using only a small number of assumptions. Methods Our approach to forecasting future COVID-19 cases involves 1) modeling the observed incidence cases using a Poisson distribution for the daily incidence number, and a gamma distribution for the series interval; 2) estimating the effective reproduction number assuming its value stays constant during a short time interval; and 3) drawing future incidence cases from their posterior distributions, assuming that the current transmission rate will stay the same, or change by a certain degree. Results We apply our method to predicting the number of new COVID-19 cases in a single state in the U.S. and for a subset of counties within the state to demonstrate the utility of this method at varying scales of prediction. Our method produces reasonably accurate results when the effective reproduction number is distributed similarly in the future as in the past. Large deviations from the predicted results can imply that a change in policy or some other factors have occurred that have dramatically altered the disease transmission over time. Conclusion We presented a modelling approach that we believe can be easily adopted by others, and immediately useful for local or state planning.
Collapse
|
14
|
Friston KJ, Parr T, Zeidman P, Razi A, Flandin G, Daunizeau J, Hulme OJ, Billig AJ, Litvak V, Price CJ, Moran RJ, Lambert C. Second waves, social distancing, and the spread of COVID-19 across the USA. Wellcome Open Res 2021; 5:103. [PMID: 33954262 PMCID: PMC8063524 DOI: 10.12688/wellcomeopenres.15986.3] [Citation(s) in RCA: 9] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 03/05/2021] [Indexed: 12/15/2022] Open
Abstract
We recently described a dynamic causal model of a COVID-19 outbreak within a single region. Here, we combine several instantiations of this (epidemic) model to create a (pandemic) model of viral spread among regions. Our focus is on a second wave of new cases that may result from loss of immunity-and the exchange of people between regions-and how mortality rates can be ameliorated under different strategic responses. In particular, we consider hard or soft social distancing strategies predicated on national (Federal) or regional (State) estimates of the prevalence of infection in the population. The modelling is demonstrated using timeseries of new cases and deaths from the United States to estimate the parameters of a factorial (compartmental) epidemiological model of each State and, crucially, coupling between States. Using Bayesian model reduction, we identify the effective connectivity between States that best explains the initial phases of the outbreak in the United States. Using the ensuing posterior parameter estimates, we then evaluate the likely outcomes of different policies in terms of mortality, working days lost due to lockdown and demands upon critical care. The provisional results of this modelling suggest that social distancing and loss of immunity are the two key factors that underwrite a return to endemic equilibrium.
Collapse
Affiliation(s)
- Karl J. Friston
- The Wellcome Centre for Human Neuroimaging, University College London, London, WC1N 3BG, UK
| | - Thomas Parr
- The Wellcome Centre for Human Neuroimaging, University College London, London, WC1N 3BG, UK
| | - Peter Zeidman
- The Wellcome Centre for Human Neuroimaging, University College London, London, WC1N 3BG, UK
| | - Adeel Razi
- The Wellcome Centre for Human Neuroimaging, University College London, London, WC1N 3BG, UK
- Turner Institute for Brain and Mental Health, Monash University, Clayton, VIC, 3800, Australia
| | - Guillaume Flandin
- The Wellcome Centre for Human Neuroimaging, University College London, London, WC1N 3BG, UK
| | - Jean Daunizeau
- Institut du Cerveau et de la Moelle épinière, INSERM UMRS 1127, Paris, France
| | - Oliver J. Hulme
- Danish Research Centre for Magnetic Resonance, Centre for Functional and Diagnostic Imaging and Research, Copenhagen University Hospital Hvidovre, Hvidovre, Denmark
- London Mathematical Laboratory, Hammersmith, UK
| | | | - Vladimir Litvak
- The Wellcome Centre for Human Neuroimaging, University College London, London, WC1N 3BG, UK
| | - Catherine J. Price
- The Wellcome Centre for Human Neuroimaging, University College London, London, WC1N 3BG, UK
| | - Rosalyn J. Moran
- Centre for Neuroimaging Science, Department of Neuroimaging, IoPPN, King's College London, London, UK
| | - Christian Lambert
- The Wellcome Centre for Human Neuroimaging, University College London, London, WC1N 3BG, UK
| |
Collapse
|
15
|
Miles DK, Stedman M, Heald AH. "Stay at Home, Protect the National Health Service, Save Lives": A cost benefit analysis of the lockdown in the United Kingdom. Int J Clin Pract 2021; 75:e13674. [PMID: 32790942 PMCID: PMC7435525 DOI: 10.1111/ijcp.13674] [Citation(s) in RCA: 37] [Impact Index Per Article: 12.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/16/2020] [Revised: 08/08/2020] [Accepted: 08/10/2020] [Indexed: 02/06/2023] Open
Abstract
INTRODUCTION The COVID-19 pandemic has transformed lives across the world. In the UK, a public health driven policy of population "lockdown" has had enormous personal and economic impact. METHODS We compare UK response and outcomes with European countries of similar income and healthcare resources. We calibrate estimates of the economic costs as different % loss in Gross Domestic Product (GDP) against possible benefits of avoiding life years lost, for different scenarios where current COVID-19 mortality and comorbidity rates were used to calculate the loss in life expectancy and adjusted for their levels of poor health and quality of life. We then apply a quality-adjusted life years (QALY) value of £30,000 (maximum under national guidelines). RESULTS There was a rapid spread of cases and significant variation both in severity and timing of both implementation and subsequent reductions in social restrictions. There was less variation in the trajectory of mortality rates and excess deaths, which have fallen across all countries during May/June 2020. The average age at death and life expectancy loss for non-COVID-19 was 79.1 and 11.4 years, respectively, while COVID-19 were 80.4 and 10.1 years; including adjustments for life-shortening comorbidities and quality of life plausibly reduces this to around 5 QALY lost for each COVID-19 death. The lowest estimate for lockdown costs incurred was 40% higher than highest benefits from avoiding the worst mortality case scenario at full life expectancy tariff and in more realistic estimations they were over 5 times higher. Future scenarios showed in the best case a QALY value of £220k (7xNICE guideline) and in the worst-case £3.7m (125xNICE guideline) was needed to justify the continuation of lockdown. CONCLUSION This suggests that the costs of continuing severe restrictions are so great relative to likely benefits in lives saved that a rapid easing in restrictions is now warranted.
Collapse
Affiliation(s)
| | | | - Adrian H. Heald
- Department of Diabetes and EndocrinologySalford Royal Hospitals NHS TrustSalfordUnited Kingdom
- The Faculty of Biology, Medicine and Health and Manchester Academic Health Sciences CentreUniversity of ManchesterManchesterUnited Kingdom
| |
Collapse
|
16
|
Vasconcelos GL, Brum AA, Almeida FAG, Macêdo AMS, Duarte-Filho GC, Ospina R. Standard and Anomalous Waves of COVID-19: A Multiple-Wave Growth Model for Epidemics. BRAZILIAN JOURNAL OF PHYSICS 2021. [PMCID: PMC8500830 DOI: 10.1007/s13538-021-00996-3] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/13/2023]
Abstract
We apply a generalized logistic growth model, with time-dependent parameters, to describe the fatality curves of the COVID-19 disease for several countries that exhibit multiple waves of infections. In the case of two waves only, the model parameters vary as a function of time according to a logistic function, whose two extreme values, i.e., for early and late times, characterize the first and second waves, respectively. For the multiple-wave model, the time-dependency of the parameters is likewise described by a multi-step logistic function with N intermediate plateaus, representing the N waves of the epidemic. We show that the theoretical curves are in excellent agreement with the empirical data for all countries considered here, namely: Brazil, Canada, Germany, Iran, Italy, Japan, Mexico, South Africa, Sweden, and the USA. The model also allows for predictions about the time of occurrence and severity of the subsequent waves. It is shown furthermore that the subsequent waves of COVID-19 can be generically classified into two main types, namely, standard and anomalous waves, according as to whether a given wave starts well after or well before the preceding one has subsided, respectively.
Collapse
Affiliation(s)
| | - Arthur A. Brum
- Departamento de Física, Universidade Federal de Pernambuco, Recife, 50670-901 Brazil
| | | | - Antônio M. S. Macêdo
- Departamento de Física, Universidade Federal de Pernambuco, Recife, 50670-901 Brazil
| | - Gerson C. Duarte-Filho
- Departamento de Física, Universidade Federal de Sergipe, São Cristóvão, 49100-000 SE Brazil
| | - Raydonal Ospina
- Departamento de Estatística, Universidade Federal de Pernambuco, Recife, 50740-540 PE Brazil
| |
Collapse
|
17
|
Conclusions. RESEARCHES AND APPLICATIONS OF ARTIFICIAL INTELLIGENCE TO MITIGATE PANDEMICS 2021. [PMCID: PMC8085314 DOI: 10.1016/b978-0-323-90959-4.00006-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
This chapter presents the usage of data science, which further helps in exploring the global pandemic COVID-19. This disease suppresses an overwhelming burden, not only to healthcare systems but to the world's economy too. In this era of techniques and technologies, it is believed that data science can better utilize scarce healthcare resources. In this chapter, we provide an introduction of data science and its applications, which helps in combating different aspects of COVID-19. Publicly available datasets related to disease are used as community resources. Different kinds of datasets are used to analyze various aspects of pandemic at different scales. These different kinds of datasets can be audio, video, textual, speech, and sensor data. More than hundreds of research articles are also studied to prepare a bibliometric study. Apart from grabbing all the advantages from datasets, this paper highlights a few challenges, such as surety of correct data, need of multidisciplinary collaboration, new data modality, security issues, and availability of data.
Collapse
|
18
|
Buchard A, Richens JG. Artificial Intelligence for Medical Decisions. Artif Intell Med 2021. [DOI: 10.1007/978-3-030-58080-3_28-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
19
|
Friston K, Costello A, Pillay D. 'Dark matter', second waves and epidemiological modelling. BMJ Glob Health 2020; 5:e003978. [PMID: 33328201 PMCID: PMC7745338 DOI: 10.1136/bmjgh-2020-003978] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/19/2020] [Revised: 11/14/2020] [Accepted: 11/17/2020] [Indexed: 12/23/2022] Open
Abstract
Recent reports using conventional Susceptible, Exposed, Infected and Removed models suggest that the next wave of the COVID-19 pandemic in the UK could overwhelm health services, with fatalities exceeding the first wave. We used Bayesian model comparison to revisit these conclusions, allowing for heterogeneity of exposure, susceptibility and transmission. We used dynamic causal modelling to estimate the evidence for alternative models of daily cases and deaths from the USA, the UK, Brazil, Italy, France, Spain, Mexico, Belgium, Germany and Canada over the period 25 January 2020 to 15 June 2020. These data were used to estimate the proportions of people (i) not exposed to the virus, (ii) not susceptible to infection when exposed and (iii) not infectious when susceptible to infection. Bayesian model comparison furnished overwhelming evidence for heterogeneity of exposure, susceptibility and transmission. Furthermore, both lockdown and the build-up of population immunity contributed to viral transmission in all but one country. Small variations in heterogeneity were sufficient to explain large differences in mortality rates. The best model of UK data predicts a second surge of fatalities will be much less than the first peak. The size of the second wave depends sensitively on the loss of immunity and the efficacy of Find-Test-Trace-Isolate-Support programmes. In summary, accounting for heterogeneity of exposure, susceptibility and transmission suggests that the next wave of the SARS-CoV-2 pandemic will be much smaller than conventional models predict, with less economic and health disruption. This heterogeneity means that seroprevalence underestimates effective herd immunity and, crucially, the potential of public health programmes.
Collapse
Affiliation(s)
- Karl Friston
- Queen Square Institute of Neurology, University College London, London, UK
| | - Anthony Costello
- Institute of Global Health, University College London, London, UK
| | - Deenan Pillay
- University College London Faculty of Medical Sciences, London, UK
| |
Collapse
|
20
|
Affiliation(s)
| | - Michael Blastland
- Winton Centre for Risk and Evidence Communication, Centre for Mathematical Sciences, University of Cambridge, Cambridge, UK
| | | |
Collapse
|
21
|
Friston KJ, Parr T, Zeidman P, Razi A, Flandin G, Daunizeau J, Hulme OJ, Billig AJ, Litvak V, Price CJ, Moran RJ, Costello A, Pillay D, Lambert C. Effective immunity and second waves: a dynamic causal modelling study. Wellcome Open Res 2020; 5:204. [PMID: 33088924 PMCID: PMC7549178 DOI: 10.12688/wellcomeopenres.16253.2] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 09/22/2020] [Indexed: 12/18/2022] Open
Abstract
This technical report addresses a pressing issue in the trajectory of the coronavirus outbreak; namely, the rate at which effective immunity is lost following the first wave of the pandemic. This is a crucial epidemiological parameter that speaks to both the consequences of relaxing lockdown and the propensity for a second wave of infections. Using a dynamic causal model of reported cases and deaths from multiple countries, we evaluated the evidence models of progressively longer periods of immunity. The results speak to an effective population immunity of about three months that, under the model, defers any second wave for approximately six months in most countries. This may have implications for the window of opportunity for tracking and tracing, as well as for developing vaccination programmes, and other therapeutic interventions.
Collapse
Affiliation(s)
- Karl J. Friston
- The Wellcome Centre for Human Neuroimaging, University College London, London, UK
| | - Thomas Parr
- The Wellcome Centre for Human Neuroimaging, University College London, London, UK
| | - Peter Zeidman
- The Wellcome Centre for Human Neuroimaging, University College London, London, UK
| | - Adeel Razi
- The Wellcome Centre for Human Neuroimaging, University College London, London, UK
- Turner Institute for Brain and Mental Health, Monash University, Clayton, VIC, 3800, Australia
| | - Guillaume Flandin
- The Wellcome Centre for Human Neuroimaging, University College London, London, UK
| | - Jean Daunizeau
- Institut du Cerveau et de la Moelle épinière, INSERM UMRS 1127, Paris, France
| | - Oliver J. Hulme
- Danish Research Centre for Magnetic Resonance, Centre for Functional and Diagnostic Imaging and Research, Copenhagen University Hospital, Hvidovre, Denmark
- London Mathematical Laboratory, Hammersmith, London, UK
| | | | - Vladimir Litvak
- The Wellcome Centre for Human Neuroimaging, University College London, London, UK
| | - Cathy J. Price
- The Wellcome Centre for Human Neuroimaging, University College London, London, UK
| | - Rosalyn J. Moran
- Centre for Neuroimaging Science, Department of Neuroimaging, IoPPN, King's College London, London, UK
| | - Anthony Costello
- UCL Institute for Global Health, Institute of Child Health, University College London, London, UK
| | - Deenan Pillay
- UCL Division of Infection and Immunity, University College London, London, UK
| | - Christian Lambert
- The Wellcome Centre for Human Neuroimaging, University College London, London, UK
| |
Collapse
|
22
|
Friston KJ, Parr T, Zeidman P, Razi A, Flandin G, Daunizeau J, Hulme OJ, Billig AJ, Litvak V, Price CJ, Moran RJ, Costello A, Pillay D, Lambert C. Effective immunity and second waves: a dynamic causal modelling study. Wellcome Open Res 2020; 5:204. [PMID: 33088924 PMCID: PMC7549178 DOI: 10.12688/wellcomeopenres.16253.1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 08/25/2020] [Indexed: 08/15/2023] Open
Abstract
This technical report addresses a pressing issue in the trajectory of the coronavirus outbreak; namely, the rate at which effective immunity is lost following the first wave of the pandemic. This is a crucial epidemiological parameter that speaks to both the consequences of relaxing lockdown and the propensity for a second wave of infections. Using a dynamic causal model of reported cases and deaths from multiple countries, we evaluated the evidence models of progressively longer periods of immunity. The results speak to an effective population immunity of about three months that, under the model, defers any second wave for approximately six months in most countries. This may have implications for the window of opportunity for tracking and tracing, as well as for developing vaccination programmes, and other therapeutic interventions.
Collapse
Affiliation(s)
- Karl J. Friston
- The Wellcome Centre for Human Neuroimaging, University College London, London, UK
| | - Thomas Parr
- The Wellcome Centre for Human Neuroimaging, University College London, London, UK
| | - Peter Zeidman
- The Wellcome Centre for Human Neuroimaging, University College London, London, UK
| | - Adeel Razi
- The Wellcome Centre for Human Neuroimaging, University College London, London, UK
- Turner Institute for Brain and Mental Health, Monash University, Clayton, VIC, 3800, Australia
| | - Guillaume Flandin
- The Wellcome Centre for Human Neuroimaging, University College London, London, UK
| | - Jean Daunizeau
- Institut du Cerveau et de la Moelle épinière, INSERM UMRS 1127, Paris, France
| | - Oliver J. Hulme
- Danish Research Centre for Magnetic Resonance, Centre for Functional and Diagnostic Imaging and Research, Copenhagen University Hospital, Hvidovre, Denmark
- London Mathematical Laboratory, Hammersmith, London, UK
| | | | - Vladimir Litvak
- The Wellcome Centre for Human Neuroimaging, University College London, London, UK
| | - Cathy J. Price
- The Wellcome Centre for Human Neuroimaging, University College London, London, UK
| | - Rosalyn J. Moran
- Centre for Neuroimaging Science, Department of Neuroimaging, IoPPN, King's College London, London, UK
| | - Anthony Costello
- UCL Institute for Global Health, Institute of Child Health, University College London, London, UK
| | - Deenan Pillay
- UCL Division of Infection and Immunity, University College London, London, UK
| | - Christian Lambert
- The Wellcome Centre for Human Neuroimaging, University College London, London, UK
| |
Collapse
|
23
|
Schaback R. On COVID-19 Modelling. JAHRESBERICHT DER DEUTSCHEN MATHEMATIKER-VEREINIGUNG. DEUTSCHE MATHEMATIKER-VEREINIGUNG 2020; 122:167-205. [PMID: 38624403 PMCID: PMC7322402 DOI: 10.1365/s13291-020-00219-9] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 01/08/2023]
Abstract
This is an analysis of the COVID-19 pandemic by comparably simple mathematical and numerical methods. The final goal is to predict the peak of the epidemic outbreak per country with a reliable technique. The difference to other modelling approaches is to stay extremely close to the available data, using as few hypotheses and parameters as possible. For the convenience of readers, the basic notions of modelling epidemics are collected first, focusing on the standard SIR model. Proofs of various properties of the model are included. But such models are not directly compatible with available data. Therefore a special variation of a SIR model is presented that directly works with the data provided by the Johns Hopkins University. It allows to monitor the registered part of the pandemic, but is unable to deal with the hidden part. To reconstruct data for the unregistered Infected, a second model uses current experimental values of the infection fatality rate and a data-driven estimation of a specific form of the recovery rate. All other ingredients are data-driven as well. This model allows predictions of infection peaks. Various examples of predictions are provided for illustration. They show what countries have to face that are still expecting their infection peak. Running the model on earlier data shows how closely the predictions follow the transition from an uncontrolled outbreak to the mitigation situation by non-pharmaceutical interventions like contact restrictions. Supplementary Information The online version of this article (10.1365/s13291-020-00219-9) contains supplementary material, which is available to authorized users.
Collapse
Affiliation(s)
- Robert Schaback
- Institut für Numerische und Angewandte Mathematik, Universität Göttingen, Lotzestraße 16-18, 37083 Göttingen, Germany
| |
Collapse
|
24
|
Friston KJ, Parr T, Zeidman P, Razi A, Flandin G, Daunizeau J, Hulme OJ, Billig AJ, Litvak V, Price CJ, Moran RJ, Lambert C. Second waves, social distancing, and the spread of COVID-19 across America. Wellcome Open Res 2020; 5:103. [PMID: 33954262 PMCID: PMC8063524 DOI: 10.12688/wellcomeopenres.15986.1] [Citation(s) in RCA: 18] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 05/22/2020] [Indexed: 08/15/2023] Open
Abstract
We recently described a dynamic causal model of a COVID-19 outbreak within a single region. Here, we combine several of these (epidemic) models to create a (pandemic) model of viral spread among regions. Our focus is on a second wave of new cases that may result from loss of immunity-and the exchange of people between regions-and how mortality rates can be ameliorated under different strategic responses. In particular, we consider hard or soft social distancing strategies predicated on national (Federal) or regional (State) estimates of the prevalence of infection in the population. The modelling is demonstrated using timeseries of new cases and deaths from the United States to estimate the parameters of a factorial (compartmental) epidemiological model of each State and, crucially, coupling between States. Using Bayesian model reduction, we identify the effective connectivity between States that best explains the initial phases of the outbreak in the United States. Using the ensuing posterior parameter estimates, we then evaluate the likely outcomes of different policies in terms of mortality, working days lost due to lockdown and demands upon critical care. The provisional results of this modelling suggest that social distancing and loss of immunity are the two key factors that underwrite a return to endemic equilibrium.
Collapse
Affiliation(s)
- Karl J. Friston
- The Wellcome Centre for Human Neuroimaging, University College London, London, WC1N 3BG, UK
| | - Thomas Parr
- The Wellcome Centre for Human Neuroimaging, University College London, London, WC1N 3BG, UK
| | - Peter Zeidman
- The Wellcome Centre for Human Neuroimaging, University College London, London, WC1N 3BG, UK
| | - Adeel Razi
- The Wellcome Centre for Human Neuroimaging, University College London, London, WC1N 3BG, UK
- Turner Institute for Brain and Mental Health, Monash University, Clayton, VIC, 3800, Australia
| | - Guillaume Flandin
- The Wellcome Centre for Human Neuroimaging, University College London, London, WC1N 3BG, UK
| | - Jean Daunizeau
- Institut du Cerveau et de la Moelle épinière, INSERM UMRS 1127, Paris, France
| | - Oliver J. Hulme
- Danish Research Centre for Magnetic Resonance, Centre for Functional and Diagnostic Imaging and Research, Copenhagen University Hospital Hvidovre, Hvidovre, Denmark
- London Mathematical Laboratory, Hammersmith, UK
| | | | - Vladimir Litvak
- The Wellcome Centre for Human Neuroimaging, University College London, London, WC1N 3BG, UK
| | - Catherine J. Price
- The Wellcome Centre for Human Neuroimaging, University College London, London, WC1N 3BG, UK
| | - Rosalyn J. Moran
- Centre for Neuroimaging Science, Department of Neuroimaging, IoPPN, King's College London, London, UK
| | - Christian Lambert
- The Wellcome Centre for Human Neuroimaging, University College London, London, WC1N 3BG, UK
| |
Collapse
|